Idenix HCV drug put on hold
Shares in Idenix have plummeted about 40% after news US regulators have placed a partial hold on the company’s experimental hepatitis C drug IDX184 following safety concerns. - News - PharmaTimes
by Katrina Megget
https://www.pharmatimes.com/news/idenix_hcv_drug_put_on_hold_976778